ONC BeiGene Oncology Company Short-Term Debt

BeiGene Corp (ONC) - corporate logo

Scaling the distribution of anticancer drugs activates operating leverage, reducing the impact of R&D costs for BeiGene Ltd (ONC). The total amount of short-term debt reflects liability dynamics, where the value of 0.31 characterizes this level. Growth is supported by strategic molecule licensing alliances and global agreements with pharma behemoths to accelerate drug market entry via a network of international oncology centers.

beigene.com (ONC) - Company Short-Term Loans and Borrowings from 07/04/2022 to 10/30/2026

Summary analytical data breakdowns for BeiGene Oncology (ONC)

- stock price and consensus target price:
Stock Price BeiGene|ONC - Average Forecast Price
- market capitalization data:
Market Value BeiGene Ltd|ONC - Value Adjusted for Debt and Cash
- shareholders' equity book value data:
Accounting Value per Share BeiGene|ONC - Accounting Value of Company|Market Capitalization to Book Value Ratio beigene.com|ONC - Cumulative Company Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio BeiGene Ltd|ONC - Long-Term Debt to Capital|Short-Term Debt to Equity BeiGene Ltd|ONC - Aggregate Debt Obligations|Debts to Book Capitalization BeiGene Ltd|ONC - Long-Term Debt|Company Short-Term Debts BeiGene|Quick Ratio beigene.com
- earnings and valuation multiples indicators:
ONC - Company Net Income
General company analysis:BeiGene (ONC)
Flagship merchandise of BeiGene Ltd

The financial stability of BeiGene Ltd (ONC) depends directly on the efficiency of its current liability management. This indicator measures the volume of loans maturing within one year, revealing hidden spikes in debt load. By analyzing the short-term debt snapshot, an investor sees real-time liquidity dynamics beyond the scope of quarterly reports. For this oncology pioneer, such control is critical when scaling global innovations. Stability in payments confirms its status as a reliable biotechnological leader.

Main competitors

Halozyme - Company Short-Term Debts|Short-Term Debt Revolution Medicines Inc|Ascentage (AAPG) - Company Short-Term Debt|CG Oncology Therapeutics - Company Short-Term Loans and Borrowings|Company Current Liabilities URGN|BCAX: Company Short-Term Loans and Borrowings|Company Short-Term Debts PSNL|Company Current Liabilities Erasca Inc ERAS|Delcath - Company Current Liabilities|Company Short-Term Debts Y-mAbs Corp YMAB|AURA - Company Short-Term Debt|Company Short-Term Loans and Borrowings CADL (Candel Therapeutics)|ARAY: Company Short-Term Debts|Short-Term Debt SELLAS Life Sciences Group (SLS)|ACTU (Actuate Therapeutics, Inc) - Company Short-Term Debts|Company Short-Term Debt CTOR|Company Short-Term Debts HURA|TARA - Short-Term Debt|Company Short-Term Debts FATE (Fate Therapeutics)|Short-Term Debt Volume Aadi Bioscience, Inc. (WHWK)|TScan - Company Short-Term Debts|Short-Term Indebtedness Champions Oncology (CSBR)|XBIT: Company Short-Term Debts|Short-Term Debt CEL-SCI (CVM)|Company Short-Term Debt OS Therapies|Company Short-Term Indebtedness RADX (Radiopharm Theranostics Ltd)|Company Short-Term Debts ARTV|ANL - Short-Term Debt|Veru Inc. - Company Current Liabilities|Company Short-Term Loans and Borrowings TPST|XLO - Company Short-Term Debt|RENB: Company Short-Term Debt|MURA (muraloncology.com) - Company Current Liabilities|KAPA: Amount of Current Liabilities|OKUR (OnKure Therapeutics, Inc.) - Company Short-Term Debts|Company Short-Term Indebtedness GDTC (CytoMed)|Company Short-Term Debt Curis, Inc. (CRIS)|APLM - Short-Term Debt|Company Short-Term Debt Tharimmune Corp THAR|ADVB: Company Short-Term Indebtedness|Genprex, Inc. - Company Short-Term Debts|Calidi Biotherapeutics (CLDI) - Company Current Liabilities|SBFM: Company Short-Term Debts|Company Current Liabilities Xenetic Biosciences, Inc.|SLRX (Salarius) - Company Short-Term Debts|Company Short-Term Debts Kitov Pharma|Company Short-Term Debt American Oncology Network (AONC)|beigene.com - Company Short-Term Indebtedness|Company Short-Term Debts CKPT (Checkpoint Therapeutics, Inc.)|ELEV - Company Current Liabilities|iCAD Corp - Company Short-Term Debts|Short-Term Debt Ikena Oncology, Inc.|Notable Labs, Ltd. (NTBL) - Company Short-Term Debt|Viracta Therapeutics, Inc. - Company Short-Term Loans and Borrowings|Company Current Liabilities MOR|NAYA: Company Short-Term Loans and Borrowings|Company Short-Term Debts AAPGV